X0508 4 2026-01-31 0001438533 Travere Therapeutics, Inc. TVTX 0001698262 ROTE WILLIAM E. C/O TRAVERE THERAPEUTICS, INC. 3611 VALLEY CENTRE DRIVE, STE 300 SAN DIEGO CA 92130 false true false false Chief Research Officer 1 Common Stock 2026-01-31 4 A 0 20090 0 A 121533 D Common Stock 2026-02-03 4 S 0 12446 32.87 D 109087 D Employee stock option (right to buy) 33.095 2026-01-31 4 A 0 53570 0 A 2036-01-31 Common Stock 53570 53570 D Each restricted stock unit represents a contingent right to receive one share of the Common Stock of the Issuer. This sale was made pursuant to a written plan adopted on May 29, 2025, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of shares to cover the tax obligation that occurred upon the vesting of restricted stock units. One-fourth of the shares subject to the stock option vest and become exercisable on the first anniversary of the date of grant, and the remaining shares vest in 36 equal monthly installments thereafter. /s/ Elizabeth E. Reed, Attorney-in-Fact 2026-02-03